Medical device company Apyx Medical Corporation (NASDAQ:APYX) stated on Monday its impressive preliminary sales performance for the full year and fourth quarter ended 31 December 2019.

For full year 2019 , the company expects total revenue from continuing operations in a range of approximately USD27.9 to USD28.1m, a rise of approximately 67% to 68% year-over-year. Advanced Energy revenue in a range of approximately USD22.3 to USD22.6m, a growth of approximately 71% to 73% year-over-year. OEM revenue of approximately USD5.5m, which rose approximately 52% year-over-year.

In the fourth quarter of 2019, the company anticipates revenue from continuing operations in a range of approximately USD8.1 to USD8.3m, an improvement of approximately 36% to 41% year-over-year. Advanced Energy revenue of approximately USD6.6 to USD6.9m, an increase of approximately 52% to 58% year-over-year.

The OEM revenue of approximately USD1.5m was generated in the fourth quarter of 2019, a dip of approximately 7% year-over-year.